Bronte Capital Management Pty Ltd. Sells 3,085 Shares of iShares Biotechnology ETF $IBB

Bronte Capital Management Pty Ltd. decreased its holdings in iShares Biotechnology ETF (NASDAQ:IBB) by 4.3% in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 69,265 shares of the financial services provider’s stock after selling 3,085 shares during the period. iShares Biotechnology ETF accounts for about 1.2% of Bronte Capital Management Pty Ltd.’s holdings, making the stock its 19th biggest position. Bronte Capital Management Pty Ltd. owned 0.14% of iShares Biotechnology ETF worth $11,695,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Dynamic Wealth Strategies LLC raised its holdings in iShares Biotechnology ETF by 16.6% during the 4th quarter. Dynamic Wealth Strategies LLC now owns 422 shares of the financial services provider’s stock valued at $71,000 after acquiring an additional 60 shares during the period. Flagship Private Wealth LLC grew its position in shares of iShares Biotechnology ETF by 2.0% in the fourth quarter. Flagship Private Wealth LLC now owns 3,084 shares of the financial services provider’s stock valued at $521,000 after purchasing an additional 60 shares in the last quarter. Larson Financial Group LLC raised its stake in shares of iShares Biotechnology ETF by 2.3% during the 4th quarter. Larson Financial Group LLC now owns 2,717 shares of the financial services provider’s stock valued at $458,000 after purchasing an additional 60 shares during the period. Webster Bank N. A. raised its stake in shares of iShares Biotechnology ETF by 1.0% during the 4th quarter. Webster Bank N. A. now owns 6,476 shares of the financial services provider’s stock valued at $1,093,000 after purchasing an additional 62 shares during the period. Finally, Choreo LLC lifted its holdings in iShares Biotechnology ETF by 2.2% during the 4th quarter. Choreo LLC now owns 3,043 shares of the financial services provider’s stock worth $514,000 after purchasing an additional 65 shares in the last quarter. 62.45% of the stock is owned by institutional investors.

iShares Biotechnology ETF Stock Performance

Shares of NASDAQ IBB opened at $195.70 on Friday. iShares Biotechnology ETF has a 52 week low of $127.11 and a 52 week high of $195.99. The business has a 50-day simple moving average of $172.76 and a two-hundred day simple moving average of $171.67.

iShares Biotechnology ETF Cuts Dividend

The company also recently disclosed a quarterly dividend, which was paid on Thursday, June 18th. Stockholders of record on Monday, June 15th were given a $0.0238 dividend. This represents a $0.10 dividend on an annualized basis and a dividend yield of 0.0%. The ex-dividend date was Monday, June 15th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.